Trajan device helps women monitor egg count

Women in Australia will be able to collect blood samples at home and mail them to a lab for analysis of their ovarian reserve or egg count using technology delivered by WHEN Fertility and Trajan Scientific and Medical.

The WHEN Fertility Egg Count Check will use Trajan’s Neoteryx Mitra device (IVD, pictured)) with its patented VAMS technology for easy finger-stick blood sample collection.

The sampling kits allow Australian women interested in their reproductive health to be more proactively involved in finding out the status of their anti-Mullerian hormone (AMH) – all without leaving home. Egg count is investigated by testing for AMH.

The kit is designed to provide Australians with their egg count status so that patients are well informed prior to visits to GPs and fertility specialists

The CEO and Co-Founder of Trajan Scientific and Medical Stephen Tomisich said Trajan’s microsampling devices were being used around the globe by people at home, who can mail their self-collected blood samples to a designated lab for accurate analysis.

Tomisich said: “This approach is enabling clinicians and researchers to remotely measure and monitor a range of health conditions, including kidney disease, psoriatic arthritis, and cancer, among others.

“The partnership with WHEN allows Trajan’s microsampling technology to support the delivery of information to Australians wishing to know more about their reproductive health.”

WHEN was founded by Sydney-based husband and wife team Maz Coote and Brett Barnes after their own fertility struggle.

Professor William Ledger, Co-Chief Medical Advisor said: “Egg count is not a comprehensive measure of a woman’s fertility but it can help identify those who are at risk of a depleted egg count earlier than expected.

“By making those women aware, we can help them consider their options and make more informed decisions along their fertility journey.”

Once a woman’s home-collected Mitra blood samples arrive in the lab, they will be processed and analysed to generate a confidential report of the results with the relevant context of what the numbers mean for the patient.

A tele-education appointment with one of WHEN’s fertility nurses is also included for anyone who receives a low result so they can be sure to understand what it does and doesn’t mean.

Picture: Trajan Scientific and Medical/Neoteryx Mitra